IL-10 polymorphism and cell-mediated immune response to Chlamydia trachomatis

Genes and Immunity

Volumn 7, Issue 3, 2006, Pages 243-249

  Ohman H ^a   Tiitinen, A ^b   Halttunen, M ^b   Birkelund, S ^c   Christiansen, G ^c   Koskela, P ^a   Lehtinen, M ^a   Paavonen, J ^b   Surcel, Helja Marja ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c AARHUS UNIVERSITY   (Denmark)

Author keywords

Chlamydial immunity; IL 10 and Chlamydia; In vitro infection

Indexed keywords

ADENINE; CD14 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; GAMMA INTERFERON; GUANINE; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANTIGEN SPECIFICITY; ARTICLE; CELLULAR IMMUNITY; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE ASSOCIATION; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IN VITRO STUDY; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; MALE; MONOCYTE; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION;

ADOLESCENT; ADULT; ANTIBODIES, BACTERIAL; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; CYTOKINES; FEMALE; HUMANS; IMMUNITY, CELLULAR; INTERFERON TYPE II; INTERFERON-GAMMA; INTERLEUKIN-10; MIDDLE AGED; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); PROMOTER REGIONS, GENETIC;

CHLAMYDIA; CHLAMYDIA TRACHOMATIS;

EID: 33646156208     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/sj.gene.6364293     Document Type: Article

References (31)

1. Cohen CR, Brunham RC. Pathogenesis of Chlamydia induced pelvic inflammatory disease. Sex Transm Infect 1999; 75: 21-24.
2. Witkin SS, Linhares I, Giraldo P, Jeremias J, Ledger WJ. Individual immunity and susceptibility to female genital tract infection. Am J Obstet Gynecol 2000; 183: 252-256.
3. Loomis WP, Starnbach MN. T cell responses to Chlamydia trachomatis. Curr Opin Microbiol 2002; 5: 87-91.
4. Stagg AJ, Tuffrey M, Woods C, Wunderink E, Knight SC. Protection against ascending infection of the genital tract by Chlamydia trachomatis is associated with recruitment of major histocompatibility complex class II antigen-presenting cells into uterine tissue. Infect Immun 1998; 66: 3535-3544.
5. Igietseme JU, Black CM, Caldwell HD. Chlamydia vaccines: Strategies and status. BioDrugs 2002; 16: 19-35.
6. Debattista J, Timms P, Allan J, Allan J. Reduced levels of gamma-interferon secretion in response to chlamydial 60 kDa heat shock protein amongst women with pelvic inflammatory disease and a history of repeated Chlamydia trachomatis infections. Immunol Lett 2002; 81: 205-210.
7. Cohen GR, Koochesfahani KM, Meier AS, Shen C, Karunakaran K, Ondondo B et al. Immunoepidemiologic profile of Chlamydia trachomatis infection: importance of heat-shock protein 60 and interferon-γ. J Infect Dis 2005; 192: 591-599.
8. Yang X, HayGlass KT, Brunham RC. Genetically determined differences in IL-10 and IFN-gamma responses correlate with clearance of Chlamydia trachomatis mouse pneumonitis infection. J Immunol 1996; 156: 4338-4344.
9. Igietseme JU, Anabana GA, Bolier J, Bowers S, Moore T, Belay T et al. Suppression of endogenous IL-10 gene expression in dendritic cells enhances antigen presentation for specific Th1 induction: Potential for vaccine development. J Immunol 2000; 164: 4212-4219.
10. Yang X, Gartner J, Zhu L, Wang S, Brunham BC. IL-10 gene knockout mice show enhanced Th1-like protective immunity and absent granuloma formation following Chlamydia trachomatis lung infection. J Immunol 1999; 162: 1010-1017.
11. Kinnunen A, Surcel H-M, Halttunen M, Tiitinen A, Morrison RP, Morrison SG et al. Chlamydia trachomatis heat shock protein-60 induced interferon-g and interleukin-10 production in infertile women. Clin Exp Immunol 2003; 131: 299-303.
12. Cohen CR, Sinei SS, Bukusi EA, Bwayo JJ, Holmes KK, Brunham RC. Human leukocyte antigen class II DQ alleles associated with Chlamydia trachomatis tubal infertility. Obstet Gynecol 2000; 95: 72-77.
13. Cohen CR, Gichui J, Rukaria R, Sinei SS, Gaur LK, Brunham RC. Immunogenetic correlates for Chlamydia trachomatisassociated tubal infertility. Obstet Gynecol 2003; 101: 438-444.
14. Kinnunen AH, Surcel H-M, Lehtinen M, Karhukorpi J, Tiitinen A, Halttunen M et al. HLA DQ alleles and interleukin-10 polymorphism associated with Chlamydia trachomatis-related tubal factor infertility: A case-control study. Hum Reprod 2002; 17: 2073-2078.
15. Mocellin S, Panelli MC, Wang E, Nagorsen D, Marincola FM. The dual role of IL-10. Trends Immunol 2003; 24: 36-43.
16. Wang C, Tang J, Geisler WM, Crowley-Nowick PA, Wilson CM, Kaslow RA. Human leukocyte antigen and cytokine gene variants as predictors of recurrent Chlamydia trachomatis infection in high-risk adolescents. J Infect Dis 2005; 191: 1084-1092.
17. Natividad A, Wilson J, Koch O, Holland MJ, Rockett K, Faal N et al. Risk of trachomatous scarring and trichiasis in Gambians varies with SNP haplotypes at the interferon-gamma and interleukin-10 loci. Genes Immun 2005; 6: 332-340.
18. Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 1997; 24: 1-8.
19. Kinnunen A, Molander P, Morrison R, Lehtinen M, Karttunen R, Tiitinen A et al. Chlamydial heat shock protein 60-specific T cells in inflamed salpingeal tissue. Fertil Steril 2002; 77: 162-166.
20. Cohen CR, Nguti R, Bukusi EA, Lu H, Shen C, Luo M et al. Human immunodeficiency virus type 1-infected women exhibit reduced interferon-g secretion after Chlamydia trachomatis stimulation of peripheral blood lymphocytes. J Infect Dis 2000; 182: 1672-1677.
21. Shemer Y, Sarov I. Inhibition of growth of Chlamydia trachomatis by human gamma interferon. Infect Immun 1985; 48: 592-595.
22. Beatty WL, Byrne GI, Morrison RP. Morphologic and antigenic characterization of interferon g-mediated persistent Chlamydia trachomatis infection in vitro. Proc Natl Acad Sci USA 1993; 90: 3998-4002.
23. Hogan RJ, Mathews SA, Mukhopadhyay S, Summersgill JT, Timms P. Chlamydial persistence: Beyond the biphasic paradigm. Infect Immun 2004; 72: 1843-1855.
24. Opal SM,Wherry JC, Grint P. Interleukin-10: Potential benefits and possible risks in clinical infectious diseases. Clin Infect Dis 1998; 27: 1497-1507.
25. Byrne GI, Lehmann LK, Landry GJ. Induction of tryptophan catabolism is the mechanism for gamma-interferon-mediated inhibition of intracellular Chlamydia psittaci replication in T24 cells. Infect Immun 1986; 53: 347-351.
26. Chu HW, Honour JM, Rawlinson CA, Harbeck RJ, Martin RJ. Effects of respiratory Mycoplasma pneumoniae infection on allergen-induced bronchial hyperresponsiveness and lung inflammation in mice. Infect Immun 2003; 71: 1520-1526.
27. Abbas AK, Murphy KM, Sher A. Functional diversity of helper T lymphocytes. Nature 1996; 383: 787-793.
28. Elenkov IJ. Glucocorticoids and the Th1/Th2 balance. Ann NY Acad Sci 2004; 1024: 138-146.
29. Karhukorpi J, Karttunen R. Genotyping interleukin-10 high and low producers with single-tube bidirectional allelespecific amplification. Exp Clin Immunogenet 2001; 18: 67-70.
30. Saikku P, Wang SP. Chlamydia trachomatis immunotypes in Finland. APMIS 1987; 95: 131-134.
31. Surcel H-M, Syrjälä H, Leinonen M, Saikku P, Herva E. Cellmediated immunity to Chlamydia pneumoniae measured as lymphocyte blast transformation in vitro. Infect Immun 1993; 61: 2196-2199.